Clinical Trial Update: Intraarterial Carboplatin + Caelyx vs Intraarterial Carboplatin + Etoposide Phosphate for Progressing Glioblastoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing intraarterial carboplatin plus Caelyx to intraarterial carboplatin plus etoposide phosphate for progressing glioblastoma; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Caelyx (liposomal doxorubicin)
• Etoposide phosphate (etoposide phosphate)

Snippet

Sponsor: Université de Sherbrooke | Conditions: Glioblastoma Multiforme, Relapse | Phase 2 | Status: RECRUITING